Capricor Therapeutics reported $24K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Bioline Rx BLRX:US $ 21.07M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Cytokinetics CYTK:US $ 0.08M 0M
Cytori Therapeutics CYTX:US $ 0.02M 0M
Geron GERN:US $ 0.32M 0M
Newlink Genetics NLNK:US $ 0.08M 0M
Prothena PRTA:US $ 0.47M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vascular Biogenics VBLT:US 173K 1.6M
Vital Therapies VTL:US $ 0M 0M